Novartis AG | |
Stock Exchange | Other OTC |
EPS |
$5.27 |
Market Cap |
$206.19 B |
Shares Outstanding |
2.55 B |
Public Float |
- |
Novartis AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR4.49 |
Market Cap |
EUR183.81 B |
Shares Outstanding |
2.55 B |
Public Float |
- |
Novartis AG ADR | |
Stock Exchange | Mexican Stock Exchange |
EPS |
MXN102.01 |
Market Cap |
MXN4 T |
Shares Outstanding |
2.32 B |
Public Float |
- |
Novartis AG ADR | |
Stock Exchange | New York Stock Exchange |
EPS |
$5.26 |
Market Cap |
$206.92 B |
Shares Outstanding |
2.53 B |
Public Float |
2.55 B |
Novartis AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF5.75 |
Market Cap |
CHF208.23 B |
Shares Outstanding |
2.55 B |
Public Float |
2.3 B |
Address |
Lichtstrasse 35 Basel Basel-Stadt (Basle Town) 4056 Switzerland |
Employees | - |
Website | http://www.novartis.com |
Updated | 07/08/2019 |
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. |